Diálisis con albúmina MARS (Molecular Adsorbent Recirculating System) como puente para el trasplante hepático en insuficiencia hepática fulminante: presentación de 3 casos

The most successful therapy for acute liver failure is liver transplantation. However, due to the low number of donors, organ support therapies need to be used as a bridge to liver transplantation. Molecular Adsorbents Recirculating System (MARS) is a dialysis treatment that uses a recirculating dia...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Contreras B,Jorge, Poniachik T,Jaime, Oksenberg R,Dan, Cortés M,Claudia, Valera M,José Miguel, Cotera F,Alejandro, Pacheco D,Alejandro, Segovia S,Erico, Sanhueza V,María Eugenia, Boltansky B,Andrés, Rojas C,Jorge, Guerrero,Julia, Díaz J,Juan Carlos
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2004
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000500010
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:The most successful therapy for acute liver failure is liver transplantation. However, due to the low number of donors, organ support therapies need to be used as a bridge to liver transplantation. Molecular Adsorbents Recirculating System (MARS) is a dialysis treatment that uses a recirculating dialysate containing albumin. This allows the removal of both hydrosoluble and albumin-related substances. This system improves hepatic encephalopathy, renal dysfunction and some clinical parameters in acute liver failure, but there is no clear decrease in mortality. We report three women aged 23, 21 and 61 years, that were subjected to liver transplantation, in whom this therapy was successfully used (Rev Méd Chile 2004; 132: 601-7).